StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.65+0.05 (+1.39%)

Close on Nov 19, 2026Market cap $525.20MP/E 24.8Yield –

Anbio Biotechnology shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 44M, up 3.3% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202544M+3.3%
FY2024Dec 31, 202442M+97.3%
FY2023Dec 31, 202321M+21435215.0%
FY2022Dec 31, 20220M–

More Anbio Biotechnology figures

See a number that looks wrong?